Travere Therapeutics
Travere Fights for FDA Approval Despite Filspari’s Trial Endpoint Miss
Anika Sharma
Travere Therapeutics has recently encountered setbacks in two critical trials involving their drug Filspari, with implications for its accelerated approval ...
Filspari fails to confirm kidney benefit in IgAN, but Travere hopes to keep FDA approval
Anika Sharma
Half a year after securing accelerated approval for the treatment of a rare kidney ailment, Travere Therapeutics’ groundbreaking drug, Filspari, ...
